Global Atherectomy Devices Market by Device Type, Application, End User 2022

The growth witnessed by atherectomy devices market is mainly driven by the growing target patient population, continuous product development & commercialization, favorable medical reimbursements, rising demand for minimally invasive atherectomy procedures, and strengthening distribution channels of major product manufacturers.

The global atherectomy devices market is projected to reach USD 1.45 Billion by 2022 from USD 1.08 Billion in 2017, at a CAGR of 6.1%. 

This report broadly segments the atherectomy devices market into product, application, end user, and region. 

On the basis of product, the market is categorized into directional, photo-ablative (laser), orbital, rotational atherectomy systems, and support devices. In 2017, the directional atherectomy devices segment is expected to account for the largest share of the market. It is also expected to register the highest CAGR during the forecast period. This can be attributed to the significant availability of credible clinical data to validate their clinical efficacy, rising availability of reimbursements for vascular treatment procedures across developed countries, high preference for minimally invasive procedures among medical professionals, clinical benefits offered, and ongoing technology advancements in the field of directional atherectomy.

Based on application, the atherectomy devices market is categorized into peripheral vascular, cardiovascular, and neurovascular applications. The peripheral vascular applications segment accounted for the largest share of the market and is expected to be the fastest growing segment during the forecast period. The large share of this segment is attributed to the significant availability of clinical evidence to support therapeutic efficacy of atherectomy in PVD treatment and rising availability of medical reimbursements for peripheral atherectomy procedures across developed countries.

Based on end user, the atherectomy devices market is segmented into three categories, namely, hospitals and surgical centers, ambulatory care centers, and research laboratories & academic institutes. The hospitals and surgical centers segment accounted for the largest share of the market due to the increasing adoption of atherectomy for cardiac & peripheral vascular disease treatment and growing availability of healthcare reimbursements across major countries.

This report covers the atherectomy devices market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). Of the four geographic regions studied in the report, North America is expected to command the largest share of the market in 2017. Factors such as increasing availability of reimbursements for atherectomy systems, growing adoption of atherectomy systems among medical professionals, large patient population of peripheral & coronary artery diseases, and growing number of clinical trials (that aim to evaluate the therapeutic efficacy of atherectomy systems in specific disease treatment) are driving the growth of the North American atherectomy devices market.

                               

To Know More @ https://www.marketsandmarkets.com/Market-Reports/atherectomy-devices-market-133112140.html

Professional Dental Care Market Share, Size and Industry Growth ..

Geographically, the global professional dental care market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, Europe commanded a major share of the market. 

However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to rising geriatric population, increasing awareness about dental health, and medical tourism will drive the growth of this market in the APAC.

Some of the prominent players in the professional dental care market include Colgate-Palmolive Company (U.S.), The Procter & Gamble Company (U.S.), Unilever plc (U.K.), Johnson & Johnson (U.S.), Young Innovation, Inc. (U.S.), Ultradent Products, Inc. (U.S.), GC Corporation (Japan), GlaxoSmithKline plc (U.K.), Dr. Fresh, LLC (U.S.), 3M Company (U.S.), Koninklijke Philips N.V. (Netherlands), and Sunstar (Japan).

Request for Sample @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=210346692

Target Audience:

• Manufacturers of professional dental care products
• Distributors of dental care products
• Dental R&D institutes
• Dental laboratories
• Government associations and dental practitioners
• Market research and consulting firms
• Venture capitalists and investors

The global professional dental care market is estimated to grow at a CAGR of 4.5% from 2016 to 2021 to reach USD 961.0 Million by 2021.

Factors such as growing number of small/ private dental clinics, rising incidences of dental caries, increasing disposable incomes in emerging countries, growing awareness about dental hygiene, and economic gains for dental practitioners are the major factors driving the growth of the global market. However, increasing number of large/group dental practices and reluctance to adopt dental dispensing practices by dental practitioners are expected to restrain the growth of this market to certain extent.

To Know More

https://www.marketsandmarkets.com/Market-Reports/professional-dental-care-market-210346692.html

"Global Surgical Lasers Market" - Global Industry Analysis and Forecast 2022

According to a new market research report "Surgical Lasers Market by Product Type (Carbon Dioxide, Argon, Nd:YAG & Diode Lasers), Procedure (Open, Laparoscopic & Percutaneous), & Application (Ophthalmology, Urology, Gynaecology, Dermatology, Dental, Cardiology, & Oncology) - Global forecast to 2021", published by MarketsandMarkets

Surgical Lasers Market is expected to reach USD 2.37 Billion by 2021; growing at a CAGR of 5.1% from 2016 to 2021.

A combination of bottom-up and top-down approaches was used to calculate the sizes and growth rates of the market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. In this research study, all possible parameters that affect this market have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative & qualitative data. 

Primary interviews with key opinion leaders were also used to determine the percentage shares of each product in emerging nations. The report provides qualitative insights about growth rates and market drivers for all subsegments. It maps market sizes and growth rates for each subsegment and identifies segments poised for rapid growth in each geographic region.

Lumenis (Israel), Cynosure, Inc. (U.S.), Alma Lasers (Israel), Abbott Laboratories, Inc., (U.S.), Boston Scientific Corporation (U.S.), IPG Photonics Corporation (U.S.), Spectranetics Corporation (U.S.), Biolitec AG (Austria), Fotona d.o.o. (Slovenia), and BISON MEDICAL Co., Ltd. (South Korea) are some of the key players in the surgical lasers market.

Target Audience:

• Surgical laser product manufacturing companies
• Product suppliers and distributors
• Healthcare service providers [including hospitals, specialty clinics, and ambulatory surgery centers (ASCs)]
• Research laboratories and academic institutes
• Clinical research organizations (CROs)
• Government regulatory authorities
• Independent authorities and non-government organizations
• Market research and consulting firms
• Venture capitalists

To Know More @ https://www.marketsandmarkets.com/Market-Reports/surgical-laser-market-12712582.html

Key Revenue Pockets of Dental Sterilization Market in Upcoming Years

The global dental sterilization market is projected to reach USD 1.48 billion by 2023 from USD 1.08 billion in 2018, at a CAGR of 6.6%. 

Factors such as the increasing number of dental facilities and the growing pool of dental care personnel, growing prevalence of dental ailments, and the increasing demand for cosmetic dentistry are expected to drive the market. The emerging markets are expected to provide a wide range of growth opportunities for players in the market.

In this report, the dental sterilization market is segmented based on product, end user, and region. 

On the basis of product, the market is further classified into instruments and consumables & accessories. The sterilization packaging accessories segment accounted for the largest share of the global dental sterilization consumables & accessories market in 2017.

The large share of this segment can primarily be attributed to the short life cycle of these products, which results in their repeated and frequent purchase, as opposed to instruments which are considered as a one-time investment. On the other hand, the sterilization equipment segment accounted for the largest share of the dental sterilization instruments market. This is due to the higher cost and higher adoption rate of these equipment.

On the basis of type, the sterilization equipment market is segmented into high-temperature sterilizers and low-temperature sterilizers. In 2017, the high-temperature sterilizers segment accounted for the largest share, primarily due to the high adoption rate, ease of use, and efficiency in the sterilization of complicated as well as delicate dental devices.

Among end users, the clinics segment is the fastest growing segment of the dental sterilization market. The market for this segment is mainly driven by the demand for affordable dental care and the growing number of private practices and smaller dental units in emerging countries.

Geographically, the dental sterilization market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Asia Pacific is projected to grow at the highest CAGR, owing to the growing number of dental clinics and hospitals and increasing number of dental surgical procedures. Additionally, the growth of dental tourism and the dental industry is propelling the need for effective infection control in a number of APAC countries such as India, Malaysia, and Thailand.

To Know More @ https://www.marketsandmarkets.com/Market-Reports/dental-sterilization-market-198802620.html

Surgical Staplers Market : Industry Size, Scope and Growth Analysis 2022

A number of factors such as increasing number of surgical procedures across the globe, growing preference for minimally invasive surgeries, technological advancements, and increasing preference for surgical staplers over sutures are expected to drive the growth of the market. On the other hand, high cost of devices and availability of alternative wound care techniques may hinder the growth of the market in the coming years.

The global surgical staplers market is expected to reach USD 4.78 Billion by 2022 from USD 3.38 Billion in 2017, at a CAGR of 7.2 %.

Scope of the Report

This report categorizes the global market into following segments and subsegments:

Global Surgical Staplers Market, By Product

• Manual Surgical Staplers
• Powered Surgical Staplers

Global Surgical Staplers Market, By Type

• Disposable Surgical Staplers
• Reusable Surgical Staplers

Global Surgical Staplers Market, By Application

• Abdominal & Pelvic Surgery
• General Surgery
• Cardiac and Thoracic Surgery
• Orthopedic Surgery
• Other Surgical Application

Global Surgical Staplers Market, By End User

• Hospitals
• Ambulatory Surgical Centers (ASCs) and Clinics

Global Surgical Staplers Market, By Region

• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Key Players

The surgical staplers market is duopolistic in nature, with two major players Ethicon Inc. (U.S.) and Medtronic plc (Ireland). Apart from these other prominent players of the market includes CONMED Corporation (U.S.), Smith & Nephew (U.K.), Purple Surgical Inc. (U.K.), Intuitive Surgical Inc. (U.S.), Welfare Medical Ltd. (U.K.), Reach surgical Inc. (China), Meril Life Science Pvt. Ltd. (India), Grena Ltd. (U.K.), B. Braun Melsungen AG (Germany), Dextera Surgical Inc. (U.S.), Frankenman International (China), and Becton, Dickinson and Company (U.S.).

To Know More @ https://www.marketsandmarkets.com/Market-Reports/surgical-stapler-market-79557149.html

Airway Management Devices Market: Objectives of the Study and Research Methodology- Global Forecast to 2023

The global airway management devices market was valued at USD 1.52 billion in 2017 and is projected to reach USD 2.10 billion by 2023, at a CAGR of 5.6% during the forecast period. 

Base year considered for the report is 2017 and the forecast period considered for this report is 2018–2023.

The growth of airway management devices market is majorly driven by factors such as rising prevalence of chronic respiratory diseases, increasing demand for emergency care, and high incidence of preterm babies are driving the growth of this market.

Request for Customization @ 

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=116806061

Objectives of the Study

• To define, measure, and describe the global market by type, end user, patient age, and region
• To provide detailed information about the major factors influencing market growth (drivers, restraints, challenges, and opportunities)
• To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
• To forecast the size of market segments in North America, Europe, Asia Pacific, and RoW
• To strategically analyze the market structure and profile key players in the global market and comprehensively analyze their core competencies
• To track and analyze company developments such as partnerships, agreements, and collaborations; expansions; acquisitions; product approvals; and product launches in the market

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global airway management devices market and estimate the size of other dependent submarkets. 

Various secondary sources such as, World Health Organization (WHO), World Economic Forum, World Bank, World Federation of Societies of Anaesthesiologists (WFSA), Difficult Airway Society, British Medical Association (BMA), American Lung Association, American Society of Anesthesiologists (ASA), Centers for Disease Control and Prevention (CDC), Health Canada, Paramedic Association of Canada, Eurostat, European Society of Anaesthesiology (ESA), Dubai Health Authority (DHA), press releases, directories, industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study of this market. 

Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

The major players in this market include Medtronic (Ireland), Smiths Medical (US), Teleflex (US), Ambu (US), KARL STORZ (Germany), Flexicare (US), Verathon (US), Olympus (Japan), Intersurgical (UK), SunMed (US), Vyaire Medical (US), and VBM Medizintechnik (Germany).

Read More @ https://www.marketsandmarkets.com/Market-Reports/airway-management-device-market-116806061.html

Cardiovascular Ultrasound System Market :Industry Analysis, Market Segmentation, Size And Global Forecast to 2021

The global cardiovascular ultrasound system market is projected to reach USD 1.66 Billion by 2021 from USD 1.27 Billion in 2016, at a CAGR of 5.4% from 2016 to 2021.

In this report, the global market is segmented on the basis of test type, technology, device display, end user, and region.

Market Segmentation

Cardiovascular Ultrasound System Market, by Test Type

• Transthoracic Echocardiogram
• Transesophageal Echocardiogram
• Stress Echocardiogram
• Other Echocardiograms (Fetal and Intracardiac Echocardiograms)

Cardiovascular Ultrasound System Market, by Technology

• 2D
• 3D & 4D
• Doppler Imaging

Cardiovascular Ultrasound System Market, by Device Display

• Color Display
• Black & White (B/W) Display

Cardiovascular Ultrasound System Market, by End User

• Hospitals/Cardiology Centers
• Ambulatory/Home Care
• Other End Users (Research Institutes, Medical Device and Pharmaceutical Companies)

Target Audience:

• Cardiovascular ultrasound system manufacturers
• Cardiovascular ultrasound system distributors and wholesalers
• Pharmaceutical companies
• Various research and consulting firms
• Research institutes
• Contract manufacturing organizations (CMOs)
• Original equipment manufacturers (OEMs)

Europe is expected to account for the largest market share during the forecast period.

The cardiovascular ultrasound system market is divided into four major regions-North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2016, Europe is expected to account for the largest share of this market, followed by North America. Factors such as growing product commercialization, expansion in clinical applications of HIFU coupled with their early commercialization in Europe, and growing emphasis on non-invasive procedures by patients and physicians are driving the growth of this market

To Know More @ https://www.marketsandmarkets.com/Market-Reports/cardiovascular-ultrasound-system-market-50389652.html

Gel Documentation Systems Market: Industry Insights and Global Forecast to 2023

Gel Documentation Systems Market is projected to grow from USD 258 million in 2018 to USD 304 million by 2023, at a CAGR of 3.3% during the forecast period.

The major factors driving the Gel Documentation Systems Market are growing global incidence of infectious diseases and genetic disorders and increase in funding for research & development in genomics, proteomics, and electrophoresis techniques.

Report Objectives

1.  To define, describe, and forecast the global gel documentation systems market on the basis of product, light source, detection technique, application, end user, and region
2. To provide detailed information regarding major factors influencing growth of the market (drivers, restraints, and opportunities)
3.  To strategically analyze the micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
4. To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
5. To forecast the revenue of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World
6. To strategically profile the key players and comprehensively analyze their market shares and core competencies2
7. To track and analyze competitive developments such as new product launches; agreements, partnerships, and joint ventures; mergers and acquisitions; and research & development activities in the gel documentation systems market

Based on region, the gel documentation systems market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2018, North America is estimated to account for the largest share due to the increasing research in the fields of proteomics and genomics, increasing R&D activities by pharmaceutical and biotechnology companies, the presence of a highly developed biotechnology research infrastructure, and the availability of government grants to support research activities.

The major players in the gel documentation systems market are GE Healthcare (US), Bio-Rad Laboratories, inc. (US), Thermo Fisher Scientific (US), LI-COR Biosciences (US), Endress+Hauser Management AG (Switzerland), Vilber Lourmat (France), Scientific Digital Imaging plc (UK), Bio-Techne (US), Cleaver Scientific (US), and Azure Biosystems (US).

To Know More @ https://www.marketsandmarkets.com/Market-Reports/gel-documentation-systems-market-17162887.html

Atherectomy Devices Market by Product , Application , End User - Global Forecasts To 2022

                                  

The global atherectomy devices market is projected to reach USD 1.45 Billion by 2022 from USD 1.08 Billion in 2017, at a CAGR of 6.1%.

The growth witnessed by atherectomy devices is mainly driven by the growing target patient population, continuous product development & commercialization, favorable medical reimbursements, rising demand for minimally invasive atherectomy procedures, and strengthening distribution channels of major product manufacturers.

Scope of the Report

This report categorizes the global atherectomy devices market into the following segments and sub segments:

Global Atherectomy Devices Market, by Product

• Directional Atherectomy Devices
• Orbital Atherectomy Devices
• Photo-Ablative Atherectomy Devices
• Rotational Atherectomy Devices
• Support Devices

Global Atherectomy Devices Market, by Application

• Peripheral Vascular
• Cardiovascular
• Neurovascular

Global Atherectomy Devices Market, by End User

• Hospitals & Surgical Centers
• Ambulatory Care Centers
• Research Laboratories & Academic Institutes

Factors such as stringent regulatory framework, significant adoption of alternative therapies, and dearth of well-trained surgeons to conduct atherectomy procedures are expected to restrain the growth of the atherectomy devices market during the forecast period.

The major players in the atherectomy devices market are Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), Cardiovascular Systems (US), Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), and Avinger (US).

To Know More @ https://www.marketsandmarkets.com/Market-Reports/atherectomy-devices-market-133112140.html

Point of Care Molecular Diagnostics Market : Industry Growth and Opportunities-Global Forecast to 2023

Growth in the point-of-care (POC) molecular diagnostics market is mainly driven by factors such as the increasing worldwide prevalence of infectious diseases, rising focus on decentralized diagnostics, and the growing demand for CLIA-waived molecular POC tests.
​Point of Care Molecular Diagnostics Market by Product & Service (Assays, Kits, Analyzers, Software), Application (Respiratory Disease, Hospital Acquired Infection), Technology (RT-PCR, INAAT), End User (Physician Office, ICUS) - Global Forecast to 2023", published by MarketsandMarkets™

Global market is expected to reach USD 1440.2 Million by 2023 from USD 725.5 Million in 2018, at a CAGR of 14.7%.

By product, the assays & kits segment is expected to dominate the market in 2018 

On the basis of product & service, the market is broadly segmented into assays & kits, instruments/analyzers, software & services. The assays & kits segment is expected to hold the largest share of the market in 2018 and is also projected to grow at highest CAGR in the global POC Molecular Diagnostics Market during the forecast period. An increasing number of assays and kits in this market have been granted the CLIA-waived status, which defines that the product can be used for decentralized settings or nontraditional laboratories, including physicians' offices, emergency rooms, and health department clinics. As a result, their applications have increased, making them the largest segment.

RT-PCR technology segment is expected to account for largest share of the market in 2018 

On the basis of technology, the market is broadly segmented into RT-PCR, INAAT, and other technologies. The RT-PCR segment is expected to account for the largest share of the global POC Molecular Diagnostics Market in 2018. RT-PCR is a highly cost-effective and preferred technology for POC settings that allows for the concurrent monitoring of expression levels of multiple genetic messages. Such benefits are driving the growth of the RT PCR segment.

Based on application, the respiratory segment is expected to account for largest share of the market in 2018 

On the basis application, the market is broadly segmented into respiratory diseases, hospital-acquired infections (HAIs), sexually transmitted diseases (STDs), oncology, hepatitis, and other applications (meningococcal meningitis, malaria, herpes simplex virus, Ebola, Zika virus). The respiratory application segment is expected to account for the largest share of the global POC Molecular Diagnostics Market in 2018. Growth in this market can be attributed to the rising prevalence of influenza and TB and the rising demand for the early diagnosis and detection of these diseases, especially in emerging countries.

Ask for PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=143524127  

Based on end user, the physician offices segment is expected to account for largest share of the market in 2018 

On the basis of end users, the market is broadly segmented into physician offices, hospital EDs and ICUs, research institutes, and other end users. The physician offices segment is expected to hold the largest share of the market. This share can be attributed to the increased preference for CLIA-waived tests for influenza diagnostics and faster turnaround time of POC molecular assay tests.

North America is expected to dominate the POC Molecular Diagnostics Market in 2018 

In 2018, North America is expected to account for the largest share of the global POC Molecular Diagnostics Market. The growing prevalence of infectious diseases, increasing number of CLIA product approvals, and rising government initiatives to support the adoption of POC molecular diagnostics in this region are driving the market growth.

Some of the key players in the global POC Molecular Diagnostics Market are Roche Diagnostics (Switzerland), Abbott Laboratories (US), Biomerieux SA (France), and Danaher (US). Product development was the major strategy adopted by these major players to maintain their leadership position in the global POC Molecular Diagnostics Market.

Know more about the Point of Care Molecular Diagnostics Market: 

https://www.marketsandmarkets.com/Market-Reports/point-of-care-molecular-diagnostic-market-143524127.html

Future of Veterinary Surgical Instruments Market - Forecast to 2021

"Veterinary Surgical Instruments Market by Product (Sutures, Foreceps, Scissors, Electrosurgery Instruments, Cannulas), Animal (Canines, Felines, Large Animals) & Applications (Soft tissue, Sterilization, Gynecology, & Orthopedic Surgery) - Forecast to 2021"published by MarketsandMarkets,

Analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and Rest of the World.

Browse 175 market data tables
32 figures
244 pages and in-depth TOC on "Veterinary Surgical Instruments Market "
http://www.marketsandmarkets.com/Market-Reports/veterinary-surgical-instrument-market-212886010.html
Early buyers will receive 10% customization on this report.

The veterinary surgical instruments market witnessed healthy growth during the last decade and is expected to grow at a CAGR of 6.6% between 2016 and 2021 to reach 1029.0 Million by 2021.

The growth in this market is majorly attributed to factors such as rising animal healthcare expenditure, rising pet adoption, increasing number of veterinary practitioners and their growing income levels in developed regions, and increasing demand for pet insurance.

The global veterinary surgical instruments market is segmented based on product, animal, application, and geography. Based on product type, the market is segmented into sutures, staplers and accessories, handheld devices, electro-surgery instruments, and others. The handheld devices are further segmented into forceps, scalpels, surgical scissors, hooks & retractors, and trocars & cannulas. Based on animal type, the market is segmented into small animals and large animals.

The small animals segment is further segmented into canines, felines, and other small animals, while the large animals segment is further segmented into equines and other large animals. Based on the application the veterinary surgical instruments market is segmented into soft- tissue surgery, sterilization surgery, gynecology & urology, dental surgery, orthopedic surgery, ophthalmic surgery and others. Similarly, on the basis of geography, the veterinary surgical instruments market is segmented into Europe, North-America, Asia-Pacific, and Rest of the World.

In 2015, sutures, staplers, and accessories accounted for the largest share of the global veterinary surgical instruments. However, electro-surgery instruments segment is expected to witness the highest growth over the next five years. The high growth in this segment can be attributed to the advantages such as easy handling, high sensitivity, accuracy, and rapid healing offered by the electrode pencils used in various surgeries of small and large animals.

Speak to our research experts:
http://www.marketsandmarkets.com/speaktoanalyst.asp?id=212886010

North America is the largest regional segment for veterinary surgical instruments owing to the well-established animal healthcare market. The largest share of this regional segment is driven by rising companion animal adoption and healthcare expenditure, growing number of veterinary practitioners and their income levels, and rising demand for pet insurance. However, the market in the Asia-Pacific region is expected to grow at the highest CAGR, owing to rising pet adoption and increasing demand for animal-derived food products in India and China.

The market players, namely, B. Braun Vet Care GmbH (Germany), Medtronic Plc. (Ireland), Ethicon Inc. (U.S.), and JORGEN KRUSSE A/S (Denmark) held the major share of the veterinary surgical instruments market and will continue to dominate the market between 2016 and 2021.

Some of the major players operating in this market are Jorgensen Laboratories (U.S.), Smiths Group Plc (U.K.), Neogen Corporation (U.S.), Integra LifeSciences Holdings Corporation (U.S.), Ethicon Inc. (U.S.), Steris Corporation (U.S.), DRE Veterinary (U.S.), GerMedUSA, Inc. (U.S.), Surgical Holdings (U.K.), Sklar Surgical Instruments (U.S.), World Precision Instruments, Inc. (U.S.), Surgical Direct (U.S.), Antibe Therapeutics Inc. (Canada), and iM3 (U.S.).

Cardiovascular Ultrasound System Market Worth 1.66 Billion USD by 2021

Cardiovascular Ultrasound System Market Test Type (Transesophageal, Stress, Transthoracic, Fetal), Technology (2D, 3D & 4D, Doppler Imaging), Device Display (Black & White, Color), End User (Hospitals, Home Care, Ambulatory) - Forecast to 2021" published by MarketsandMarkets, the market is projected to reach USD 1.66 Billion by 2021 from USD 1.27 Billion in 2016, growing at a CAGR of 5.4% during the forecast period (2016-2021).

Browse 93 market data Tables and 40 Figures spread through 164 Pages and in-depth TOC on"Cardiovascular Ultrasound System Market "

http://www.marketsandmarkets.com/Market-Reports/cardiovascular-ultrasound-system-market-50389652.html

Early buyers will receive 10% customization on this report. 

The report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the cardiovascular ultrasound market along with the estimates and forecasts of the revenue. Increasing incidence of cardiovascular diseases, technological advancements, and advantages of echocardiography over invasive cardiac diagnostic procedures are the major drivers for the Cardiovascular Ultrasound System Market. However, insufficient reimbursement scenario and economic impact of adopting new technologies are restraining the growth of the market.

The Cardiovascular Ultrasound System Market is broadly segmented into test type, technology, device display, end user, and region. Based on test type, the market is categorized into transthoracic echocardiogram, stress echocardiogram, transesophageal echocardiogram, and fetal & intracardiac echocardiogram. The stress echocardiogram segment is expected to account for the largest share of the market in 2016. This is due to the major advantage of the stress echocardiogram that it can provide data of the cardiac muscles and valves before and after the stress of the heart muscle.

Enquiry Before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=50389652

On the basis of technology, the Cardiovascular Ultrasound System Market is segmented into 2D, 3D & 4D, and Doppler imaging. The 2D technology is estimated to account for the largest share of the market in 2016, whereas the 3D & 4D technology segment is estimated to grow at the highest CAGR during the forecast period.

On the basis of device display, the market is segmented into color display and black & white (B/W) display. The color display segment is expected to register the highest growth in 2016.

On the basis of end user, the Cardiovascular Ultrasound System Market is categorized into hospitals, cardiology centers, ambulatory, home care, and other end users (research institutes, medical device and pharmaceutical companies). The hospitals segment is expected to account for the largest share of the market in 2016. The home care & ambulatory segment is estimated to register the highest CAGR during the forecast period due to increase in the usage of echocardiographs at the patient's house itself.

Buy Now: https://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=50389652

Key players in the Cardiovascular Ultrasound System Market include GE Healthcare (U.S.), Philips healthcare (The Netherlands), Siemens Healthcare (Germany), Hitachi Medical Corporation (Japan), and Toshiba Medical Systems Corporation (Japan).

Atherectomy Devices Market - Global Forecasts to 2022

Atherectomy Devices Market by Type (Hydrodynamic, Ultrasound, Aspiration, Mechanical Thrombectomy), Application (Cardiovascular, Peripheral, Neurovascular), End User (Hospitals, Surgical Centers, Ambulatory, Academia, CROs) - Global Forecasts to 2022

​Factors such as favorable reimbursement scenario for atherectomy procedures, increasing number of research activities in the field of atherectomy, and increasing healthcare expenditure are driving the growth of the market.

The report studies the global Atherectomy Devices Market over the forecast period of 2017 to 2022. The market is projected to reach USD 1.45 Billion by 2022 from USD 1.08 Billion in 2017, at a CAGR of 6.1%. 
Browse 77 Market Data Tables and 47 Figures spread through 149 Pages and in-depth TOC on "Atherectomy Devices Market"
http://www.marketsandmarkets.com/Market-Reports/atherectomy-devices-market-133112140.html
Early buyers will receive 10% customization on this report 

Based on product, the directional atherectomy devices segment is expected to witness the highest growth during the forecast period. 

On the basis of product, the Atherectomy Devices Market is categorized into directional, orbital, photo-ablative (laser), rotational atherectomy devices, and support devices. In 2017, the directional atherectomy devices segment accounted for the largest share of the market. It is also expected to register the highest CAGR during the forecast period. This can be attributed to clinical benefits offered (such as lack of barotrauma, less risk of neointimal hyperplasia, immediate change of bypass site, and availability of differently sized instruments to enable atherectomy in blood vessels) and ongoing technological advancements in the field of directional atherectomy.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=133112140
Based on application, the peripheral vascular applications segment is estimated to have the largest share of the market in 2017. 

Based on application, the market is categorized into peripheral vascular, cardiovascular, and neurovascular applications. The peripheral vascular applications segment accounted for the major share of the market owing to the significant availability of clinical evidence to support the therapeutic efficacy of atherectomy in PVD treatment and growing patient preference for minimally invasive surgical procedures.

Based on end user, the hospitals and surgical centers segment is expected to witness the highest growth during the forecast period. 

Based on end user, the market is segmented into hospitals & surgical centers, ambulatory care centers, and research laboratories & academic institutes. The hospitals and surgical centers segment is expected to register the highest CAGR during the forecast period. The large share of this segment is attributed to increasing adoption of atherectomy for cardiac & peripheral vascular disease treatment, ongoing technological advancements in the field of minimally invasive or image-guided atherectomy procedures, rising incidence of chronic vascular diseases, and growing availability of healthcare reimbursements across major countries.

Talk To Our Research Analysts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=133112140

North America is expected to dominate the Atherectomy Devices Market in 2017. 

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the market in 2017, followed by Europe. Factors such as increasing availability of reimbursements for atherectomy devices, growing adoption of atherectomy devices among medical professionals, large patient population of peripheral & coronary artery diseases, and growing number of clinical trials are driving the growth of the North American Atherectomy Devices Market. 

However, Asia Pacific is expected to register the highest growth rate during the forecast period. This can be attributed to the increasing prevalence of target diseases, increasing healthcare expenditure, cost-effective (owing to the increase in localized manufacturing and strengthening of distribution networks of key product manufacturers), and rising awareness among surgeons related to the benefits offered by atherectomy systems (less revascularization rates, high efficacy, short procedural time).

Major players operating in the Atherectomy Devices Market are Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), and Cardiovascular Systems (US). Other prominent players present in this market include Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), and Avinger (US).